Test Price
2,800 AED✅ Home Collection Available
MYO1A Gene Autosomal Dominant Deafness Type 48 (DFNA48) Genetic Test in UAE
2,800 AED · 2026 DHA Guidelines
تحليل جين MYO1A للصمم الوراثي السائد من النوع 48 (DFNA48) بتقنية التسلسل الجيني الجديد في الإمارات
2,800 درهم · معتمد من هيئة الصحة بدبي
الملخص التنفيذي: Executive Summary
- Accuracy Guarantee: 99.9% diagnostic sensitivity – full MYO1A gene coverage via NGS, interpreted by board‑certified clinical geneticists.
- Premium Logistics: Paid hospital‑grade home collection with ISO‑certified cold‑chain transport. VIP mobile phlebotomy available 8 AM‑11 PM.
- Clinical Guidance: Tele‑phonic post‑test clinical result interpretation and genetic counselling support.
- Insurance: Direct billing verification through WhatsApp: +971 54 548 8731.
DHA Licensed Facility: 9834453 · ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139)
Overview
The MYO1A DFNA48 NGS test diagnoses autosomal dominant non‑syndromic hearing loss by sequencing the entire MYO1A gene. يكشف هذا التحليل الطفرات في جين MYO1A المسؤولة عن فقدان السمع الوراثي السائد، مما يتيح تشخيصًا دقيقًا واستشارة وراثية مستنيرة.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | NGS full‑gene sequencing (99.9% sensitivity) | Single‑gene Sanger (targets known hotspots only) |
| Method | Illumina® platform + CNV analysis | PCR‑based cascading screening |
| Speed | Report in 3–4 weeks | Often >6 weeks with incomplete resolution |
| Clinical Integration | Includes post‑test genetic counselling | Report only, no interpretation |
Physician Insight & Safety Protocol
“As a senior consultant, I emphasize that a genetic result must always be correlated with the full audiologic and family history. The MYO1A test provides a definitive molecular diagnosis for DFNA48, yet normal results do not exclude other genetic forms of deafness. We are here to guide you through the implications, ensuring that every result is understood in the right clinical context.”
— Dr. Prabhakar Reddy, DHA License 61713011
Do not discontinue, modify, or initiate any medication without direct consultation with your treating physician. This test does not replace medical therapy for hearing loss.
Patient Safety – Before You Proceed
- Exclusion Criteria: Individuals who have not received mandatory pre‑test genetic counselling; patients unwilling to share detailed pedigree or clinical history; individuals under 18 years without legal guardian consent (per UAE CDS Law 2026, Art. 12).
- Emergency Red Flags (seek immediate ENT/ER care): Sudden severe hearing loss with vertigo or tinnitus; acute ear pain with discharge; any neurological signs (facial weakness, imbalance) – the test result is not an emergency diagnostic tool.
Patient FAQ & Clinical Guidance
Q: How accurate is the MYO1A NGS test for diagnosing DFNA48 hearing loss?
Snippet: This achieves over 99.9% analytical sensitivity and specificity for MYO1A variants, making it the gold standard for confirming DFNA48 autosomal dominant deafness in symptomatic individuals.
All variants are classified according to ACMG guidelines, and the report includes clinical interpretation to rule of other syndromic forms.
ما مدى دقة فحص جين MYO1A لتشخيص فقدان السمع DFNA48؟
يحقق هذا الفحص حساسية ونوعية تحليلية تتجاوز 99.9% لتغيرات جين MYO1A، مما يجعله المعيار الذهبي لتأكيد الصمم الوراثي السائد من النوع 48 لدى الأفراد المصابين بأعراض.
Q: What samples are accepted and how is home collection arranged?
Snippet: You can provide whole blood (EDTA tube), extracted DNA, or a single drop of blood on an FTA card, and our VIP phlebotomist reaches your home or office between 8 AM and 11 PM daily.
All specimens are transported in ISO‑validated cold‑chain containers, ensuring DNA integrity until processing at our DHA‑licensed facility.
ما هي العينات المقبولة وكيف يتم ترتيب التجميع المنزلي؟
يمكنك تقديم عينة دم كامل (أنبوبة EDTA) أو حمض نووي مستخلص أو قطرة دم واحدة على بطاقة FTA، ويصل أخصائي الفصد المتنقل إلى منزلك أو مكتبك يوميًا بين 8 صباحًا و11 ليلاً.
Q: Will my genetic data remain confidential under UAE law?
Snippet: Absolutely; all personal and genomic data are processed in strict compliance with UAE Federal Decree‑Law No. 41 of 2024 and the Personal Data Protection Law, and never shared without your explicit consent.
Your sample is coded and stored in a secure biobank for a limited period, and you retain full control over data withdrawal requests.
هل ستبقى بياناتي الجينية سرية بموجب القانون الإماراتي؟
تمامًا؛ حيث تُعالج جميع البيانات الشخصية والجينومية وفقًا للمرسوم بقانون اتحادي رقم 41 لعام 2024 وقانون حماية البيانات الشخصية الإماراتي، ولا تُشارك مطلقًا دون موافقة صريحة منك.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians